Amgen 2015 Annual Report Download - page 45
Download and view the complete annual report
Please find page 45 of the 2015 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35 -
36 -
37 -
38 -
39 -
40 -
41 -
42 -
43 -
44 -
45 -
46 -
47 -
48 -
49 -
50 -
51 -
52 -
53 -
54 -
55 -
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
 |
 |
37
Stock repurchase program
During the three months and year ended December 31, 2015, we had one outstanding stock repurchase program, under which
the repurchasing activity was as follows:
Total
number of
shares
purchased
Average
price paid
per share(1)
Total number
of shares
purchased as
part of
publicly
announced
program
Maximum dollar
value that may
yet be purchased
under the
program(2)
October 1 - October 31 709,600 $ 140.92 709,600 $ 5,000,000,000
November 1 - November 30 339,608 $ 158.37 339,608 $ 4,946,215,002
December 1 - December 31 188,807 $ 158.38 188,807 $ 4,916,311,000
1,238,015 $ 148.37 1,238,015
January 1 - December 31 11,990,992 $ 154.49 11,990,992
(1) Average price paid per share includes related expenses.
(2) In October 2015, our Board of Directors authorized an increase that resulted in a total of $5.0 billion available under the
stock repurchase program.
Dividends
For the years ended December 31, 2015 and 2014, we paid quarterly dividends. We expect to continue to pay quarterly
dividends, although the amount and timing of any future dividends are subject to approval by our Board of Directors. Additional
information required by this item is incorporated herein by reference to Part IV—Note 15, Stockholders’ equity, to the Consolidated
Financial Statements.
Securities Authorized for Issuance Under Existing Equity Compensation Plans
Information about securities authorized for issuance under existing equity compensation plans is incorporated by reference
from Item 12—Securities Authorized for Issuance Under Existing Equity Compensation Plans.